Status:

Do Not Prescribe (DNP), Red

Decision Date:

None

Comments

RED:

• SSC2613 Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma. NHSE commissioned. (Decision date - March 2024)

DNP:

• NICE TA700: Selinexor with low-dose dexamethasone for treating refractory multiple myeloma (terminated appraisal) (Decision date - June 2021)

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again